OTCMKTS:CNBTF Cannara Biotech (CNBTF) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CNBTF Stock Alerts $0.63 +0.03 (+5.00%) (As of 05/20/2024 ET) Add Share Share Today's Range$0.63▼$0.6450-Day Range$0.54▼$0.7352-Week Range$0.08▼$0.20Volume736 shsAverage Volume33,127 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Cannara Biotech alerts: Email Address Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. About Cannara Biotech Stock (OTCMKTS:CNBTF)Read More CNBTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNBTF Stock News HeadlinesApril 17, 2024 | cnbc.comThe average tax refund is more than $130 larger than it was in 2023 -- here's whyApril 11, 2024 | cnbc.comHow to get the student loan interest deductionApril 10, 2024 | cnbc.comHow to use your HSA as a retirement savings toolApril 7, 2024 | cnbc.comHere's the average net worth of Americans ages 35 to 44April 1, 2024 | cnbc.comThe most exclusive credit cards on the market right nowApril 1, 2024 | cnbc.com5 best business cards for LLCs: Earn rewards while tracking expensesMarch 20, 2024 | cnbc.comShizuka McNeillMarch 20, 2024 | cnbc.com2024 federal income tax brackets — how much will you pay?March 19, 2024 | cnbc.comWhen are taxes due? Here are the federal and state filing deadlines for 2024March 15, 2024 | cnbc.comHere are the best Visa credit cards for rewards and special financingMarch 15, 2024 | cnbc.comHere's when the Federal Reserve could cut interest rates in 2024March 15, 2024 | cnbc.comWaiting on your tax refund? Here's how you can check its status with the IRSMarch 9, 2024 | cnbc.comThe 4 best second-chance checking accounts of 2024March 7, 2024 | cnbc.comThe top premium checking accounts offering waived fees, loan discounts, VIP event access and moreMarch 6, 2024 | cnbc.comHere’s when you should expect to receive your tax refund in 2024February 11, 2024 | cnbc.comThis is the special credit score lenders use when you apply for a mortgageFebruary 10, 2024 | cnbc.comHere are 4 money moves you should make to set yourself up for financial success in 2024February 2, 2024 | cnbc.comThese top budgeting apps can help you spend and save smarterJanuary 30, 2024 | cnbc.comHere's why now is the perfect time to put your savings in a CDJanuary 30, 2024 | cnbc.comThese are the best checking account bonuses of February 2024January 17, 2024 | cnbc.comSocial Security benefits have increased — here's how much more you'll receiveJanuary 14, 2024 | cnbc.comHere are the 5 best credit cards for couples — married or notJanuary 13, 2024 | cnbc.comHere's the best high-yield savings account for doing all your banking in one placeJanuary 3, 2024 | morningstar.comCannara Biotech Inc LOVEDecember 22, 2023 | cnbc.comTurboTax's software is easy to use but can be expensive for complicated returnsSee More Headlines Receive CNBTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:CNBTF CUSIPN/A CIKN/A Webcannara.ca PhoneN/AFaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Zohar Krivorot (Age 42)Founder, Pres, CEO & Director Mr. Lennie Ryer CPA (Age 58)CPA, CA, CFE, VP of Fin. & CFO Mr. Evan MorrisChief Operating OfficerMs. Julia BouvetChief of Staff CNBTF Stock Analysis - Frequently Asked Questions How have CNBTF shares performed in 2024? Cannara Biotech's stock was trading at $0.63 at the start of the year. Since then, CNBTF stock has increased by 0.0% and is now trading at $0.63. View the best growth stocks for 2024 here. How do I buy shares of Cannara Biotech? Shares of CNBTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CNBTF) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannara Biotech Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
